Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
MPI-676
print preview
bookmark
share with colleague
General Information
Company
Meditrina Pharmaceuticals Inc.
Description
Anastrozole-based aromatase inhibitor
Molecular Target
Aromatase
Mechanism of Action
Aromatase inhibitor
Latest Stage of Development
Phase II
Indication
Endometriosis
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy